DDAVP normalized the bleeding time in patients with congenital platelet TxA2 receptor abnormality

Transfusion

Volumn 43, Issue 5, 2003, Pages 563-567

  Fuse, Ichiro ^a   Higuchi, Wataru ^b   Mito, Masao ^b   Aizawa, Yoshifusa ^b  

^a NIIGATA UNIVERSITY MEDICAL AND DENTAL HOSPITAL   (Japan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ARGININE; DESMOPRESSIN; LEUCINE; PROSTAGLANDIN SYNTHASE; RISTOCETIN; THROMBOXANE A2; THROMBOXANE A2 RECEPTOR; VON WILLEBRAND FACTOR;

ARTICLE; BERNARD SOULIER DISEASE; BLEEDING TIME; BLOOD CLOTTING; CLINICAL ARTICLE; ENZYME DEFICIENCY; GENE MUTATION; GLANZMANN DISEASE; HEMOSTASIS; HUMAN; ORAL SURGERY; THROMBOCYTE AGGREGATION; THROMBOCYTE ANOMALY; THROMBOXANE A2 RECEPTOR ABNORMALITY;

BLEEDING TIME; BLOOD COAGULATION FACTORS; BLOOD PLATELET DISORDERS; BLOOD PLATELETS; DEAMINO ARGININE VASOPRESSIN; FEMALE; HEMOSTATICS; HUMANS; MIDDLE AGED; PERIODONTAL CYST; PREOPERATIVE CARE; RECEPTORS, THROMBOXANE; THROMBOXANE A2; TOOTH EXTRACTION;

EID: 0037407051     PISSN: 00411132     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1537-2995.2003.00389.x     Document Type: Article

References (32)

1. Cuthbert RJ, Watson HH, Handa SI, Abbott I, Ludlam CA. DDAVP shortens the bleeding time in Bernard Soulier syndrome. Thromb Res 1988;49:649-50.
2. DiMichele DM, Hathaway WE. Use of DDAVP in inherited and acquired platelet dysfunction. Am J Hematol 1990;33: 39-45.
3. Waldenstrom E, Holmberg L, Axelsson U, Winqvist I, Nilsson IM. Bernard-Soulier syndrome in two Swedish families: effect of DDAVP on bleeding time. Eur J Haematol 1991;46:182-7.
4. Kemahli S, Canatan D, Uysal Z, et al. DDAVP shortens bleeding time in Bernard-Soulier syndrome. Thromb Haemost 1994;71:675.
5. Noris P, Arbustini E, Spedini P, Belletti S, Balduini CL. A new variant of Bernard-Soulier syndrome characterized by dysfunctional glycoprotein (GP) Ib and severely reduced amounts of GPIX and GPV. Br J Haematol 1998; 103:1004-13.
6. Mayer K, Schildknecht O, von Felten A. May-Hegglin anomaly: further studies on thrombocyte dysfunction. Schweiz Med Wochenschr 1997;127:1134-40.
7. Matzdorff AC, White JG, Malzahn K, Greinacher A. Perioperative management of a patient with Fechtner syndrome. Ann Hematol 2001;80:436-9.
8. Kobrinsky NL, Israels ED, Gerrard JM, et al. Shortening of bleeding time by 1-deamino-8-D-arginine vasopressin in various bleeding disorders. Lancet 1984;1:1145-8.
9. Nieuwenhuis HK, Sixma JJ. 1-desamino-8-D-arginine vasopressin (desmopressin) shortens the bleeding time in storage pool deficiency. Ann Intern Med 1988;108: 65-7.
10. Van Dorp DB, Wijermans PW, Meire F, Vrensen G. The Hermansky-Pudlak syndrome. Variable reaction to 1-desamino-8D-arginine vasopressin for correction of the bleeding time. Ophthalmic Paediatr Genet 1990;11: 237-44.
11. Espanol I, Hernandez A, Pujol RM, Urrutia T, Pujol-Moix N. Type IV Ehlers-Danlos syndrome with platelet delta-storage pool disease. Ann Hematol 1998;77: 47-50.
12. Schulman S, Johnsson H, Egberg N, Blömback M. DDAVP-induced correction of prolonged bleeding time in patients with congenital platelet function defects. Thromb Res 1987;45:165-74.
13. Mannucci PM, Vicente V, Vianello L, et al. Controlled trial of desmopressin in liver cirrhosis and other conditions associated with a prolonged bleeding time. Blood 1986;67: 1148-53.
14. Mant MJ. DDAVP in Bernard-Soulier syndrome. Thromb Res 1988;52:77-8.
15. 2 activation. Blood 1993; 81:994-1000.
16. 2 receptor in a dominantly inherited bleeding disorder. J Clin Invest 1994;94: 1662-7.
17. 2 binding activity. Thromb Haemost 1996;76:1080-5.
18. 2 binding activity. Thromb Haemost 1999;82:1528-31.
19. 2. Semin Thromb Haemost 2000;26: 43-5.
20. 2 in a patient with congenital platelet cyclo-oxygenase deficiency. Int J Hematol 1996;63:317-24.
21. Born GVR. Aggregation of blood platelets by ADP and its reversal. Nature 1962;194:927-9.
22. Katsura M, Miyamoto N, Hamanaka N, et al. Advances in prostaglandin, thromboxane and leukotriene research. New York: Raven Press, 1983:351-7.
23. Hellem AJ. The adhesiveness of human blood platelets in vitro. Scand J Clin Lab Invest 1960;12(Suppl 51):1-117.
24. Amiral J, Adalbert B, Adam M. Application of enzyme immunoassay to coagulation testing. Clin Chem 1984;30: 1512-6.
25. Howard MA, Firkin BG. Ristocetin: a new tool in the investigation of platelet aggregation. Thrombos Diathes Haemorrh 1971;26:362-9.
26. Cattaneo M, Zighetti ML, Lombardi R, Mannucci PM. Role of ADP in platelet aggregation at high shear: studies in a patient with congenital defect of platelet responses to ADP. Br J Haematol 1994;88:826-9.
27. Cattaneo M, Pareti FI, Zighetti M, et al. Platelet aggregation at high shear is impaired in patients with congenital defects of platelet secretion and is corrected by DDAVP: correlation with the bleeding time. J Lab Clin Med 1995; 125:540-7.
28. Greinacher A, Potzsch B, Kiefel V, et al. Evidence that DDAVP transiently improves hemostasis in Bernard-Soulier syndrome independent of von Willebrand factor. Ann Hematol 1993;67:149-50.
29. Lethagen S, Nilsson IM. DDAVP-induced enhancement of platelet retention: its dependence on platelet-von Willebrand factor and the platelet receptor GP IIb/IIIa. Eur J Haematol 1992;49:7-13.
30. Martinez-Murillo C, Quintana GS, Ambriz FR, et al. Treatment of the hereditary platelet function defects as gray platelet syndrome and Bernard-Soulier syndrome with DDAVP (abstract). Blood 1994;84:688a.
31. Lozano M, Escolar G, Monteagudo J, Pico M, Ordinas A. Hemostatic effect of DDAVP infusion on a Bernard-Soulier syndrome patient: studies under flow conditions (abstract). Thromb Haemost 1995;73:985.
32. Sloand EM, Alyono D, Klein HG, et al. 1-deamino-8-D-arginine vasopressin (DDAVP) increases platelet membrane expression of glycoprotein Ib in patients with disorders of platelet function and after cardiopulmonary bypass. Am J Hematol 1994;46:199-207.